Category: Allen Institute

  • BioMarin Collaborates with Allen Institute to Develop Gene Therapies for Rare Brain Diseases

    Shots: BioMarin will receive an exclusive license to each program for research, development, and commercialization of the gene therapies The collaboration will utilize Allen institute technologies to develop new gene therapies for rare genetic diseases of CNS by targeting gene expression to specific cells Allen Institute has developed modified engineering AAVs to carry genes on […]